TPPU
SIGMA/SML0750 - ≥98% (HPLC)
Synonym: 1-
CAS Number: 1222780-33-7
Empirical Formula (Hill Notation): C16H20F3N3O3
Molecular Weight: 359.34
Linear Formula: C16H20F3N3O3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C16H20F3N3O3/c1-2-14(2 |
| InChI key | AAJMQTLFRTZCJK-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | FC(F)(F)Oc1ccc(cc1)NC(=O) |
| solubility | DMSO: 10 mg/mL, clear (warmed) |
| storage temp. | 2-8°C |
| Application: | TPPU has been used as a soluble epoxide hydrolase (SEH) inhibitor to characterize its pharmacokinetic (PK) and pharmacodynamic properties in rodents. It has also been used as a SEH inhibitor to study its effects on 12,13-dihydroxy-9Z-octade |
| Biochem/physiol Actions: | TPPU is a potent sEH inhibitor (IC50 = 3.7 nM) that has been shown to have very favorable PK attributes in cynomolgus monkeys. sEH converts epoxyeicosatrienoic acids (EETs) to dihydroxyiecosatrienoic acids (DHETs), and sEH inhibitors display anti-inflammatory and anti-atherosclerotic effects. |
| Biochem/physiol Actions: | TPPU is a potent sEH inhibitor. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51111800 |


